Document is current

Article History

Accepted: 1 November 2020

First Online: 7 November 2020

Compliance with Ethical Standards

:

: Dr. Mahajan received grant support from the Dystonia Medical Research Foundation for the conduct of this study. He reports no conflict of interest.Ms. Schroder reports no relevant financial disclosures or conflicts of interest.Dr. Dwivedi reports no relevant financial disclosures or conflicts of interest.Dr. Wang reports no relevant financial disclosures or conflicts of interest.Dr. Espay reports no relevant financial disclosures or conflicts of interest.

: Dr. Mahajan has received grant support from the Dystonia Medical Research Foundation, Sunflower Parkinson’s disease Foundation and the Parkinson’s Foundation.Ms. Schroder has nothing to disclose.Dr. Rekhtman has nothing to disclose.Dr. Dwivedi is currently supported as a co-investigator by the NIH (1R21HL143030-01) and (R21 AI133207) grants. He is also currently serving as a statistician in CPRIT-funded studies (PP200006, PP190058, PP180003, and PP170068). Dr. Dwivedi is also an Adjunct Associate Professor in the Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio.Dr. Wang is receiving grant support from the NIH as a central imaging core lab reader (NS103824-01) and UC Gardner Neuroscience Institute.Dr. Espay has received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for AbbVie, Neuroderm, Neurocrine, Amneal, Adamas, Acadia, Acorda, InTrance, Sunovion, Lundbeck, and US WorldMeds; publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer; and honoraria from US WorldMeds, Acadia, and Sunovion.